Observed Signal · May 21, 2026 · Funding · Source: techcrunch · Impact: 1/5 · Sentiment: Neutral
The Path raises $14.3M for safer AI therapy
The Path, a consumer AI therapy and coaching app co-founded by Anson Whitmer and Tyler Sheaffer with Tony Robbins as a co-founder, raised $14.3 million in seed funding led by Prime Movers Lab. The startup, built by former Calm employees, offers AI-driven interactive audio therapy with 11 virtual AI therapists and customizable preferences. Its bespoke model — post-trained from open-source models rather than major commercial LLMs — scored 95 on the Vera-MH mental-health safety benchmark (compared with a top score of 65 for consumer bots). The app is currently free while it acquires users and plans a future $40/month subscription. Seed investors also include Apolo Anton Ohno, Deontay Wilder and Designer Fund.
Early-stage seed funding for a consumer AI mental-health app; notable for AI safety benchmarking but limited direct impact on the broader AdTech/MarTech ecosystem.
MARKET SIGNALS
Track OpenAI Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- The Path raised $14.3 million in seed funding led by Prime Movers Lab.
- Tony Robbins joined The Path as a co-founder and helped shape its therapy-plus-coaching approach.
- The startup’s specially trained AI model scored 95 on the Vera-MH mental-health safety benchmark; consumer bots score up to 65.
- The Path offers 11 virtual AI therapists, is currently free, and plans a $40/month subscription.
- Founders Anson Whitmer and Tyler Sheaffer previously worked at Calm; other seed participants include Apolo Anton Ohno, Deontay Wilder and Designer Fund.
Connected Companies & Entities
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Tolan raises $30M for AI companion app
AI companion app Tolan has secured an additional $30 million in funding from Union Square Ventures, Khosla Ventures, and Homebrew. The investment doubles the startup's total raised capital and brings its estimated valuation to over $268 million, according to PitchBook. Tolan has attracted more than 250,000 active users, with over 70 million conversations logged in the past year. The app generates revenue through tiered memberships, with annual recurring revenue in the double-digit millions. The company faces competition from newer AI agents and potential risks related to AI-powered emotional support.
Instinct AI Hits $2.5B Valuation in Weeks
Instinct, a personal AI assistant founded by Noah Shinn (author of the Reflexion paper), jumped in valuation from roughly $100M to $2.5B within weeks after successive funding rounds led by Kleiner Perkins, Benchmark and Index Ventures. The product remains an invite-only, free beta with no disclosed revenue or user numbers; investors are betting it could become a “personal AI gateway.” The article highlights the technical moat as hiding complex agent self-correction and orchestration behind a simple text/call interface, and raises concerns about the deep permissions such agents require (inbox, payment methods, calendars), recommending spending caps and confirmation gates as mitigations.
Proximal Ventures Raises $27.5M for AI Drug Development Fund
Proximal Ventures, founded by former SignalFire investor Sahir Raoof, has raised $27.5 million for its debut venture capital fund. The fund will invest in pre-seed and seed-stage startups applying AI to drug development tools, infrastructure, and services. Proximal has already backed seven startups, including ChronicleBio, which uses AI to analyze biological and medical data for chronic disease research. The fund's backers include SignalFire, Kleiner Perkins, Bertelsmann Healthcare Investments, and individual investors like Dimension Capital co-founders. Raoof, who previously worked at Flatiron Health and Iterative Health, aims to capture pharmaceutical spending by offering AI-driven services that are faster and cheaper than traditional outsourcing. The fund will write checks between $500,000 and $1.5 million.
WATCHLIST & BRIEFINGS
Receive future signals for OpenAI & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor OpenAI
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
